Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer.
暂无分享，去创建一个
S. Bhide | M. Sharabiani | M. Hubank | M. Sharabiani | K. Thway | I. Garcia-Murillas | K. Newbold | K. Harrington | D. Allin | P. Carter | R. Shaikh | B. O’Leary | D. Gonzales-de-Castro | D. Kim | D. M. Allin | Paul D. Carter | Ben O'Leary | Mike Hubank | Kevin J. Harrington | Katie L. Newbold